Biolase (BIOL) Receives News Sentiment Rating of 0.12

News headlines about Biolase (NASDAQ:BIOL) have been trending somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Biolase earned a news sentiment score of 0.12 on Accern’s scale. Accern also assigned news stories about the medical technology company an impact score of 46.7208581029458 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Here are some of the media headlines that may have impacted Accern’s rankings:

How to Become a New Pot Stock Millionaire

NASDAQ:BIOL traded down $0.01 on Thursday, hitting $0.33. The stock had a trading volume of 94,398 shares, compared to its average volume of 155,778. Biolase has a 1-year low of $0.28 and a 1-year high of $1.45.

Biolase (NASDAQ:BIOL) last posted its earnings results on Wednesday, March 14th. The medical technology company reported ($0.04) earnings per share for the quarter, meeting the consensus estimate of ($0.04). The company had revenue of $12.63 million for the quarter. Biolase had a negative net margin of 35.91% and a negative return on equity of 67.04%.

ILLEGAL ACTIVITY WARNING: “Biolase (BIOL) Receives News Sentiment Rating of 0.12” was posted by Macon Daily and is the sole property of of Macon Daily. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://macondaily.com/2018/04/19/biolase-biol-receives-news-sentiment-rating-of-0-12.html.

Biolase Company Profile

BIOLASE, Inc, a medical device company, develops, manufactures, markets, and sells laser systems in dentistry and medicine in the United States and internationally. The company offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening.

Insider Buying and Selling by Quarter for Biolase (NASDAQ:BIOL)

Receive News & Ratings for Biolase Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biolase and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply